nitpicker / Shutterstock.com
12 January 2021Big PharmaMuireann Bolger
Sanofi buys Kymab in boost to immunotherapy portfolio
Already registered?
Login to your account
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk
Big Pharma
28 July 2016 Sanofi and Boehringer Ingelheim have reached an agreement to swap parts of their business.
Africa
16 November 2016 Pharmaceutical company Sanofi and its subsidiary Genzyme have recovered a domain name that infringed a trademark at the World Intellectual Property Organization’s Arbitration and Mediation Center.
Editor's picks
Editor's picks
Big Pharma
28 July 2016 Sanofi and Boehringer Ingelheim have reached an agreement to swap parts of their business.
Africa
16 November 2016 Pharmaceutical company Sanofi and its subsidiary Genzyme have recovered a domain name that infringed a trademark at the World Intellectual Property Organization’s Arbitration and Mediation Center.
Big Pharma
28 July 2016 Sanofi and Boehringer Ingelheim have reached an agreement to swap parts of their business.
Africa
16 November 2016 Pharmaceutical company Sanofi and its subsidiary Genzyme have recovered a domain name that infringed a trademark at the World Intellectual Property Organization’s Arbitration and Mediation Center.